![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospace.com/business/biomarin-brings-on-roche-amgen-alums-in-executive-restructuring
https://www.prnewswire.com/news-releases/otezla-apremilast-now-available-in-the-us-for-moderate-to-severe-pediatric-plaque-psoriasis-302225697.html
https://www.fiercepharma.com/marketing/roche-regains-reputation-crown-among-rare-disease-patient-groups-amgen-close-behind
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761024
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125522
https://www.reuters.com/business/healthcare-pharmaceuticals/us-expects-6-bln-savings-first-medicare-drug-price-negotiations-2024-08-15/
https://www.reuters.com/legal/litigation/amgen-sues-samsung-biotech-unit-over-bone-drug-copies-2024-08-13/
https://www.fiercepharma.com/pharma/approve-amgen-lung-cancer-med-imdelltra-fda-large-number-missing-adverse-events
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biotech-giant-amgen-plans-to-open-to-technology-innovation-centre-in-hyderabad/articleshow/112398585.cms
https://www.biospace.com/drug-development/5-obesity-readouts-to-watch-in-the-second-half-of-2024